categor
variabl
analyz
chisquar
test
mean
continu
variabl
compar
student
test
associ
among
continu
variabl
assess
pearson
correl
coeffici
multivari
logist
regress
backward
stepwis
analysi
perform
identifi
independ
variabl
correl
clinic
outcom
may
cox
regress
model
use
studi
surviv
data
plusminu
valu
mean
standard
deviat
p
valu
consid
signific
probabl
twotail
systat
softwar
version
spss
chicago
il
use
statist
analysi
patient
diseas
limit
resolut
fever
pneumon
two
hundr
eight
patient
either
clinic
radiolog
evid
progress
pneumon
receiv
gm
puls
dose
methylprednisolon
therapi
mainten
steroid
resum
puls
dose
therapi
patient
given
puls
dose
steroid
treat
potent
broadspectrum
intraven
antibiot
piperacillin
tazobactam
protect
hospitalacquir
infect
hyperglycemia
hypokalemia
flare
hepat
b
infect
hospitalacquir
infect
steroid
psychosi
acut
side
effect
encount
hepat
b
carrier
treat
lamivudin
mg
day
liver
failur
occur
member
cohort
diseas
progress
appar
arrest
puls
dose
steroid
therapi
patient
remain
patient
ill
ran
sever
protract
cours
patient
need
high
dose
oxygen
sixtyseven
admit
intens
care
unit
requir
ventil
support
twentysix
patient
die
male
femal
crude
mortal
rate
cohort
day
followup
ci
underestim
sampl
bia
die
april
exclud
sampl
longterm
survivor
retain
studi
among
concurr
medic
ill
healthcar
worker
cohort
die
diabet
found
three
patient
die
hypertens
four
die
eleven
die
live
amoy
garden
young
pregnant
woman
die
deliveri
despit
aggress
treatment
age
sex
healthcar
worker
statu
amoy
garden
resid
statu
presenc
coexist
condit
interv
onset
fever
therapi
ribavirin
plu
steroid
neutrophil
platelet
count
admiss
initi
creatin
kinas
lactat
dehydrogenas
level
correl
clinic
outcom
studi
variabl
p
valu
univari
analysi
enter
multivari
regress
model
multivari
logist
regress
advanc
age
high
neutrophil
count
admiss
high
initi
lactat
dehydrogenas
level
independ
correl
high
oxygen
depend
well
intens
care
unit
admiss
death
tabl
cox
backward
stepwis
regress
young
age
low
neutrophil
count
admiss
healthcar
worker
statu
favor
independ
correl
surviv
time
tabl
doserespons
relationship
also
exist
independ
correl
clinic
outcom
figur
use
term
correl
instead
predictor
outcom
method
use
case
seri
second
serolog
titer
obtain
end
second
week
neg
correl
age
pearson
admiss
lymphocyt
count
pearson
convers
neutrophil
count
admiss
posit
correl
second
serolog
titer
pearson
puls
dose
steroid
shown
affect
second
serolog
titer
pearson
patient
depend
high
oxygen
therapi
higher
second
antibodi
titer
sarsassoci
coronaviru
p
spread
diseas
healthcar
worker
major
problem
countri
deal
sar
intub
nasopharyng
aspir
chest
physiotherapi
handl
excreta
even
feed
becom
highrisk
procedur
healthcar
worker
work
hospit
author
hospit
requir
follow
recommend
person
protect
equip
standard
level
precaut
depend
risk
work
area
type
procedur
perform
healthcar
worker
work
sar
area
wore
mask
face
shield
cap
gown
surgic
glove
intens
care
unit
highrisk
area
cohort
tabl
howev
healthcar
worker
work
nonsar
area
exempt
contract
diseas
sar
patient
sought
treatment
earli
exhibit
atyp
sign
symptom
univari
analysi
healthcar
worker
statu
neg
correl
death
healthcar
worker
younger
sought
treatment
earlier
lower
neutrophil
count
lower
initi
lactat
dehydrogenas
level
admiss
tabl
nevertheless
healthcar
worker
statu
still
independ
surviv
correl
control
confound
variabl
current
safeti
precaut
could
prevent
frontlin
healthcar
worker
contract
sar
minim
individu
exposur
viru
might
reduc
viral
load
subsequ
immun
hyperact
risk
fatal
outcom
patient
cohort
treat
accord
protocol
clinic
outcom
repres
natur
histori
sar
variabl
relat
benefit
treatment
time
onset
treatment
donnelli
et
al
found
time
onset
symptom
admiss
hospit
affect
death
rate
studi
patient
sought
treatment
earli
receiv
antivir
steroid
combin
therapi
shown
better
multivari
analysi
hospit
author
adopt
aggress
treatment
protocol
peak
sar
epidem
hong
kong
broadspectrum
antibiot
combin
ribavirin
steroid
mainstay
treatment
dose
ribavirin
use
small
prevent
major
side
effect
administr
steroid
sar
treatment
controversi
howev
theoret
earli
use
steroid
promot
viral
replic
enhanc
infect
possibl
caus
rebound
infect
peiri
et
al
found
viral
load
peak
day
sar
patient
treat
ribavirin
steroid
howev
immunosuppress
precis
immunomodul
believ
effect
therapi
second
stage
sar
current
consensu
among
hospit
author
expert
panel
begin
administ
steroid
pentaglobin
second
stage
sar
hypersensit
immun
reaction
occur
patient
sought
treatment
earli
tend
receiv
antivir
therapi
later
time
understand
sinc
symptom
sar
nonspecif
clinician
also
reli
laboratori
data
diagnosi
sensit
current
rtpcr
assay
satisfactori
sensit
rapid
diagnost
test
must
develop
particularli
effect
treatment
regim
futur
one
third
sar
patient
studi
limit
diseas
cours
remain
two
third
pneumon
progress
rapidli
earli
use
ribavirin
steroid
combin
therapi
appar
approxim
one
third
respond
puls
dose
steroid
third
depend
treatment
high
amount
oxygen
intens
care
requir
patient
advanc
age
high
neutrophil
count
admiss
elev
initi
lactat
dehydrogenas
level
independ
correl
advers
clinic
outcom
strong
evid
support
earli
routin
use
ribavirin
steroid
combin
therapi
sar
patient
exist
need
investig
new
antivir
agent
test
efficaci
steroid
random
control
trial
sar
entir
new
emerg
diseas
clinic
cours
vari
wide
stratifi
patient
accord
risk
could
individu
treatment
protocol
addit
need
sensit
rapid
diagnost
test
sarsassoci
coronaviru
infect
treatment
form
cohort
patient
infect
deadli
diseas
